Board Meeting Details

The Board of Directors meeting was held on Saturday, November 14, 2026, commencing at 05:00 PM and concluding at 07:14 PM.

Key Quantitative Figures - Standalone (₹ in lakhs)

Quarter Ended September 30, 2026:

  • Revenue from operations: ₹1,857.59
  • Total revenue: ₹1,877.18
  • Total expenses: ₹2,216.32
  • Loss before tax: ₹(339.14)
  • Tax expense (deferred tax): ₹(73.08)
  • Loss for the period: ₹(266.05)
  • Total comprehensive loss: ₹(262.69)
  • Earnings per share (basic and diluted): ₹(2.01)

Half Year Ended September 30, 2026:

  • Revenue from operations: ₹3,253.38
  • Total revenue: ₹3,292.23
  • Total expenses: ₹4,082.49
  • Loss before tax: ₹(790.26)
  • Tax expense (deferred tax): ₹(182.44)
  • Loss for the period: ₹(607.82)
  • Total comprehensive loss: ₹(601.11)
  • Earnings per share (basic and diluted): ₹(4.60)

Key Quantitative Figures - Consolidated (₹ in lakhs)

Quarter Ended September 30, 2026:

  • Revenue from operations: ₹2,010.03
  • Total revenue: ₹2,020.93
  • Total expenses: ₹2,395.50
  • Loss before tax: ₹(374.57)
  • Tax expense (deferred tax): ₹(165.72)
  • Loss for the period: ₹(208.85)
  • Total comprehensive loss: ₹(207.07)
  • Earnings per share (basic and diluted): ₹(1.59)

Half Year Ended September 30, 2026:

  • Revenue from operations: ₹3,539.80
  • Total revenue: ₹3,561.46
  • Total expenses: ₹4,493.99
  • Loss before tax: ₹(932.52)
  • Tax expense (deferred tax): ₹(299.25)
  • Loss for the period: ₹(633.27)
  • Total comprehensive loss: ₹(629.72)
  • Earnings per share (basic and diluted): ₹(4.82)

Segment Reporting (Consolidated)

Pharmaceuticals Segment:

  • Q2 FY27 Revenue: ₹1,857.59 lakhs
  • Q2 FY27 Segment result: ₹(170.93) lakhs
  • Half Year FY27 Revenue: ₹3,253.38 lakhs
  • Half Year FY27 Segment result: ₹(444.89) lakhs

Printing and Packaging Segment:

  • Q2 FY27 Revenue: ₹209.96 lakhs
  • Q2 FY27 Segment result: ₹17.25 lakhs
  • Half Year FY27 Revenue: ₹421.90 lakhs
  • Half Year FY27 Segment result: ₹(30.42) lakhs

Management Change

Mrs. Preeti Sarin (DIN: 11995485) has been appointed as Additional Independent Director of the Company from November 14, 2026 to November 13, 2031 (both days inclusive) for a period of five consecutive years, subject to approval of shareholders of the Company.

Mrs. Preeti Sarin is a qualified professional with a Bachelor of Business Administration (BBA) degree and over 10 years of professional experience. She has strong understanding of business administration, management, operational coordination and organizational activities.

Auditor Qualifications and Emphasis of Matter

The statutory auditors, M/s Khurana Sharma & Co., have issued limited review reports with emphasis on the following matters:

Unpaid Statutory Dues - ANG Lifesciences (₹ in lakhs):

  • Employees' State Insurance: ₹37.15 (periods 26-27: ₹6.57, 25-26: ₹14.39, 24-25: ₹15.19)
  • Employees' Provident Fund: ₹340.99 (periods 26-27: ₹59.53, 25-26: ₹145.71, 24-25: ₹135.75)
  • Tax Deducted at Source: ₹60.55 (periods 26-27: ₹17.83, 25-26: ₹7.50, 24-25: ₹35.12)
  • Tax Collected at Source: ₹0.19 (26-27)
  • Total: ₹438.88

Unpaid Statutory Dues - Mansa Print (₹ in lakhs):

  • Employees' State Insurance: ₹8.59
  • Employees' Provident Fund: ₹113.12
  • Tax Deducted at Source: ₹44.24
  • Total: ₹165.95

Disputed Tax Demands - ANG Lifesciences (₹ in lakhs):

  • 2017-18: ₹7.15 (Appeal)
  • 2020-21: ₹2.64
  • Total: ₹9.79

Loan Defaults - ANG Lifesciences:

The company has defaulted in repayment of various credit facilities from HDFC Bank with aggregate outstanding of ₹494.08 lakhs as of September 30, 2026, including:

  • Cash Credit A/c No. 5020005195731.00: ₹163.09 lakhs outstanding, 18 months interest overdue
  • GECL A/c No. 451760402: ₹325.55 lakhs outstanding, 15 months principal & interest overdue
  • 15 Car loans: ₹2.39 lakhs outstanding, 2 months principal overdue
  • Car loan A/c No. 120026103: ₹3.05 lakhs outstanding, 2 months principal overdue

Loan Defaults - Mansa Print:

The subsidiary has defaulted in repayment of various credit facilities from HDFC Bank including:

  • Term Loan A/c No. 85390052: ₹613.63 lakhs outstanding, 15 months overdue
  • Term Loan A/c No. 85998201: ₹125.50 lakhs outstanding, 16 months overdue
  • Cash Credit A/c No. 50200058407747: ₹586.70 lakhs outstanding, 72 months interest overdue

Other Limitations

Company was unable to provide:

  • Stock statement as on September 30, 2026 for verification of drawing power against cash credit facilities
  • Certain statements (current accounts maintained before takeover from NCLT) required for verification

Financial Impact

Financial impact of the unpaid statutory dues and loan defaults has not been quantified in the disclosure.